Biotech · Private company
BJ Bioscience, Inc.
Track this companyFree. Adds BJ Bioscience, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- BJ-001Phase 1 · Locally Advanced/Metastatic Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- BJ-005Phase 1 · Advanced Solid Tumor or LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 1 · Locally Advanced/Metastatic Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A First-in-Human, Phase 1 Dose-Escalation and Cohort Expansion Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BJ-005 in Patients With Advanced Solid Tumor or LymphomaPHASE1 · UNKNOWN · started Oct 20, 2021ClinicalTrials.gov NCT05115292 · fetched Nov 12, 2026
- Safety Study of BJ-001, an IL-15 Fusion Protein, for Locally Advanced/Metastatic Solid TumorsPHASE1 · UNKNOWN · started Dec 4, 2019ClinicalTrials.gov NCT04294576 · fetched Nov 12, 2026